| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |